Skip to main content
Clinical Trials/ISRCTN76803177
ISRCTN76803177
Completed
Not Applicable

A retrospective case report series of patients (post-marketing) Receiving Olanzapine IntraMuscular Outside of Product Monograph doses and indications: assessing safety and tolerability

ondon Health Sciences Centre (Canada)0 sites10 target enrollmentAugust 31, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ondon Health Sciences Centre (Canada)
Enrollment
10
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 31, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ondon Health Sciences Centre (Canada)

Eligibility Criteria

Inclusion Criteria

  • Patients whom have received Olanzapine IM in doses exceeding doses stated in literature or for uses not listed in the current edition of the Compendium of Pharmaceuticals and Specialties.

Exclusion Criteria

  • Patients under 16 or over 70 years of age, or those whom have a documented allergy or sensitivity to olanzapine, also patients whom have used the olanzapine IM within normal dosing parameters.

Outcomes

Primary Outcomes

Not specified

Similar Trials